
51 - 200 employees
Founded 2005
🧬 Biotechnology
💊 Pharmaceuticals
🔬 Science
Biotechnology • Pharmaceuticals • Science
Capricor Therapeutics, Inc. is a clinical-stage biotechnology company developing cell- and exosome-based therapeutics, focused on precision medicine for Duchenne muscular dystrophy and other serious diseases. The company advances allogeneic cardiosphere-derived cells (CDCs) and exosome platforms across a multi-stage pipeline, including investigational cell therapy (deramiocel) and approaches for loading therapeutic oligonucleotides into exosomes. Capricor emphasizes patient-focused development, translational research, and strategic partnerships to bring novel biologic medicines to patients.
🕒 4 days ago
Medical Science Liaison Director at Capricor Therapeutics specializes in delivering scientific engagement strategies. Focused on Duchenne muscular dystrophy with a territory of national and regional KOLs.
🕒 4 days ago
MSL Director responsible for Capricor's scientific engagement strategy with KOLs treating DMD. Focused on scientific exchange, clinical opportunities, and strategy translation.
🕒 July 10
Senior Director, Patient Services at Capricor Therapeutics leading patient services infrastructure for U.S. launch of transformative cell therapies.
🕒 July 10
Senior Director overseeing Patient Services for Capricor Therapeutics, advancing therapies for rare diseases. Engaging with cross-functional teams to establish patient support and reimbursement strategies.
🕒 June 2
Medical Science Liaison Director responsible for engaging KOLs and advancing DMD treatment strategies at Capricor Therapeutics. Delivering scientific exchanges and identifying clinical opportunities within a remote role.